30Mg Pharma Limited
About 30Mg Pharma Limited
Data last updated:
30Mg Pharma Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2022PLC134033.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anil Tekriwal and Srikrishna Vishal Tekriwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D 611 Swati Crimson & Clover Nr Shilaj Circle Vill. Shilaj Tal. Daskroi, Ahmedabad, Gujarat, India – 380054.
As per the financials filed for FY 2025, the company reported a revenue of ₹15 Lakh, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹5,036 (net margin 0.3%) and EBITDA of ₹13,771 (EBITDA margin 0.9%).
Company details
Contact details
30Mg Pharma Limited's registered office is in Ahmedabad, Gujarat.
- Registered AddressD 611 Swati Crimson & Clover Nr Shilaj Circle Vill. Shilaj Tal. Daskroi, Ahmedabad, Gujarat, India – 380054
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of 30Mg Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of 30Mg Pharma Limited, buy the company report.
Financials of 30Mg Pharma Limited
FY 2025 filings available30Mg Pharma Limited reported revenue of ₹15 Lakh (up 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 40% in the latest year. EBITDA rose 67% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹13,771 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹5,036 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.9% | ||
| Net Profit Margin | 0.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of 30Mg Pharma Limited, buy the company report.
Board of directors of 30Mg Pharma Limited
30Mg Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Tekriwal Also directs: Prestige Suitings Pvt. Ltd | Director | 20 Jul 2022 | 4 Years 3 Months | Current |
| Srikrishna Vishal Tekriwal | Director | 20 Jul 2022 | 4 Years 3 Months | Current |
| Jagriti Rungta | Director | 20 Jul 2022 | 4 Years 3 Months | Current |
Peer comparison
30Mg Pharma Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr Mittal Laboratories Private Limited | ₹15 Lakh (FY 2025) | 134.0% | Dehradun, Uttarakhand, India | |||
| 30Mg Pharma Limitedthis company | ₹15 Lakh (FY 2025) | ₹5,036 | 0.3% | 40.0% | Ahmedabad, Gujarat, India | |
| Risoved Pharma Private Limited | ₹14.97 Lakh (FY 2018) | Pune, Maharashtra, India | ||||
| V-Bros Lifesciences Private Limited | ₹14.9 Lakh (FY 2021) | 41.0% | Roorkee, Uttarakhand, India |
To see the full peer comparison of 30Mg Pharma Limited, buy the company report.
Legal cases
No court or tribunal cases involving 30Mg Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for 30Mg Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for 30Mg Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
30Mg Pharma Limited has 3 board changes on record since 2022: 3 appointments. The latest: Anil Tekriwal was appointed as Director on 20 Jul 2022.
Frequently asked questions
30Mg Pharma is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 2022 (4+ years old) and is registered under CIN U24230GJ2022PLC134033.
30Mg Pharma has 3 current directors:
- Anil Tekriwal - Director
- Srikrishna Vishal Tekriwal - Director
- Jagriti Rungta - Director
The latest financial statements of 30Mg Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of 30Mg Pharma is U24230GJ2022PLC134033. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
30Mg Pharma was incorporated on 20 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of 30Mg Pharma by revenue are Dr Mittal Laboratories Private Limited, Risoved Pharma Private Limited, V-Bros Lifesciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Tekriwal was appointed as Director on 20 Jul 2022. Jagriti Rungta was appointed as Director on 20 Jul 2022. Srikrishna Vishal Tekriwal was appointed as Director on 20 Jul 2022.
The registered office of 30Mg Pharma is at D 611 Swati Crimson & Clover Nr Shilaj Circle Vill. Shilaj Tal. Daskroi, Ahmedabad, Gujarat, India – 380054.
30Mg Pharma operates in the pharma industry, in the drug formulation and development segment.
30Mg Pharma can be reached at its registered office: D 611 Swati Crimson & Clover Nr Shilaj Circle Vill. Shilaj Tal. Daskroi, Ahmedabad, Gujarat, India – 380054.
30Mg Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Ahmedabad.